🔎 Trials Near Me

Beranda › Penyakit Parkinson › Michigan › Farmington Hills

Uji klinis Penyakit Parkinson di Farmington Hills, MI

13 studi untuk Penyakit Parkinson mencari peserta di lokasi sekitar Farmington Hills (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Menerima pesertaFase 2
  • Quest Research Institute, Farmington Hills
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06680830

A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

Menerima pesertaFase 1Sukarelawan sehat diterima
  • Quest Research Institute - Alcanza, Farmington Hills
Usia 30 hingga 80 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06565195

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

Menerima pesertaFase 2/3
  • Site-015, Farmington Hills
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06976268

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

Menerima pesertaFase 2
  • Quest Research Institute, Farmington Hills
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07005180

A Study of Buntanetap in Participants With PD

Menerima pesertaFase 2/3
  • Quest Research Institute, Farmington Hills
Usia 40 hingga 85 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07284784

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

Menerima pesertaFase 2
  • Vima Site #002, Farmington Hills
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07804615

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

Menerima pesertaFase 2
  • Quest Research Institute - Alcanza - PPDS (Site #201), Farmington Hills
Usia 30 hingga 80 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07432958

A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations

Menerima pesertaFase 2
  • Quest Research Institute - Alcanza - HyperCore - PPDS, Farmington Hills
Usia 40 hingga 85 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07514858

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Menerima pesertaFase 3
  • Quest Research Institute, Farmington Hills
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07174310

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Menerima pesertaFase 3
  • Quest Research Institute, Farmington Hills
Usia 45 hingga 75 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06944522

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

Menerima pesertaFase 1
  • Quest Research Institute, Farmington Hills
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 5 Jun 2026 · NCT07422675

A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

Menerima pesertaFase 1Sukarelawan sehat diterima
  • QUEST Research Institute, Farmington Hills
Usia 30 hingga 85 · Semua jenis kelamin · Diperbarui 20 Apr 2026 · NCT06809400

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

Menerima pesertaFase 4
  • Quest Research Institute, Farmington Hills
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Agu 2025 · NCT06765668

Uji klinis Penyakit Parkinson di kota lain

Studi lain di Farmington Hills

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.